Dark

Check out our Level2View

DVAX
Dynavax Technologies Corporation
stock NASDAQ

Inactive

Feb 9, 2026

15.50USD0.000%(0.00)7,102,420

Pre-market

0.00USD-100.000%(-15.50)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 10, 2022

08:33AM EST Dynavax Announces Initiation Of Phase 1 Trial For Its Shingles Vaccine Candidate RTTNews

08:06AM EST Dynavax Announces Initiation Of Phase 1 Clinical Trial For Its Shingles Vaccine Candidate Benzinga

08:02AM EST Dynavax Highlights 2022 Priorities and Announces Initiation of Phase 1 Clinical PR Newswire

Jan 7, 2022

04:06PM EST Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

Jan 6, 2022

09:56AM EST Dynavax Technologies Corp. (DVAX) shares are gaining more than 6 percent on Thursday morning trade after, continuing an upsurge since Wednesday. There were no corporate announcements from the biopharmaceutical company today to impact the stock alert. RTTNews

05:52AM EST Valneva Confirmed Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001 Benzinga

Jan 5, 2022

04:05PM EST Dynavax to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference PR Newswire

Dec 29, 2021

08:49AM EST 10 Biggest Price Target Changes For Wednesday Benzinga

06:08AM EST HC Wainwright & Co. Maintains Buy on Dynavax Technologies, Raises Price Target to $28 Benzinga

Dec 28, 2021

11:39AM EST Dynavax Says COVID-19 Vaccine Developed By Biological E Using Co's CpG 1018 Adjuvant Receives India DCGI Approval For Emergency Use Benzinga

11:35AM EST COVID-19 Vaccine Developed by Biological E Using Dynavax's CpG 1018 Adjuvant PR Newswire

Dec 14, 2021

08:10AM EST Elaine D. Sun Appointed to Dynavax Board of Directors PR Newswire

Dec 2, 2021

04:06PM EST Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

Nov 18, 2021

04:10PM EST Dynavax to Present at the 4th Annual Evercore Virtual ISI HealthCONx Conference PR Newswire

Nov 5, 2021

09:28AM EDT Dynavax Technologies Q3 EPS $(0.24) May Not Compare To $0.05 Estimate, Sales $108.27M Beat $58.20M Estimate Benzinga

Nov 4, 2021

04:02PM EDT Dynavax Reports Third Quarter 2021 Financial Results PR Newswire

05:00AM EDT Earnings Scheduled For November 4, 2021 Benzinga

Nov 2, 2021

04:11PM EDT Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

Oct 21, 2021

04:20PM EDT Scott Myers Appointed to Dynavax Board of Directors and Elected Board Chairman PR Newswire

08:03AM EDT Dynavax to Report Third Quarter 2021 Financial Results and Host Conference Call PR Newswire

Oct 18, 2021

05:44PM EDT Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

06:44AM EDT The following are some of the stocks making big moves in Monday's pre-market trading (as of 06.30 A.M. EDT). RTTNews

05:16AM EDT Shares of Valneva Rise 34% After Company Reports Endpoints Met in Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate; Shares of Dynavax, Supplier of CpG 1018 Adjuvant, Up 7% Benzinga

02:28AM EDT COVID-19 Vaccine Developed by Valneva Using Dynavax's CpG 1018 Adjuvant Meets PR Newswire

Oct 4, 2021

08:06AM EDT Dynavax Technologies, U.S. Department Of Defense Announce Collaboration To Develop An Adjuvant Plague Vaccine Using Co's CpG 1018 Adjuvant; Terms Not Disclosed Benzinga

08:02AM EDT Dynavax and U.S. Department of Defense Announce Collaboration to Develop an PR Newswire

Oct 1, 2021

06:14PM EDT Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

Sep 28, 2021

08:18AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive Benzinga

08:16AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK To Develop Long-Acting HIV Treatments Benzinga

Sep 27, 2021

04:20PM EDT Dynavax to Present at Upcoming Investment Conferences PR Newswire

11:42AM EDT 'Dynavax: In Line for a Big Revenue Stream From Covid-19 Vaccine's Potential Approval' -TipRanks Report Benzinga

Sep 24, 2021

08:05AM EDT Cramer Shares His Thoughts On Dynavax, Nucor And Amarin Benzinga

Sep 22, 2021

11:30AM EDT Dynavax Technologies Option Alert: Nov 19 $20 Calls Sweep (14) near the Ask: 500 @ $2.351 vs 6 OI; Earnings 11/4 After Close [est] Ref=$18.155 Benzinga

11:07AM EDT Dynavax Technologies Option Alert: Nov 19 $20 Calls Sweep (4) near the Ask: 200 @ $2.35 vs 6 OI; Earnings 11/4 After Close [est] Ref=$18.088 Benzinga

07:11AM EDT Dynavax PR Highlights News Of Clover Biopharmaceuticals Data For COVID-19 Vaccine Using Dynavax Adjuvent Benzinga

07:09AM EDT 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial PR Newswire

06:58AM EDT Clover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta In Global Phase 2/3 SPECTRA Trial Dominated By Variants Of Concern And Interest Benzinga

Sep 13, 2021

10:09AM EDT Why Dynavax Shares Are Trading Lower Today Benzinga

09:04AM EDT Benzinga Pro's Top 5 Stocks To Watch For Monday, Sept. 13, 2021: JKS, NEGG, DVAX, BLU, MDXG Benzinga

08:45AM EDT Cramer Weighs In On Hut 8 Mining Corp, Ping Identity Holding And More Benzinga

07:25AM EDT Dynavax Shares Fall 8& Premarket After UK Ends Covid-19 Vaccine Supply Deal Using Co's Booster Benzinga

06:10AM EDT The following are some of the stocks making big moves in Monday's pre-market trading (as of 5.45 A.M. EDT). RTTNews

02:52AM EDT Dynavax : U.K. Terminates Valneva's Supply Agreement For COVID-19 Vaccine Candidate, VLA2001 RTTNews

02:30AM EDT Dynavax Provides Update on its COVID-19 Collaboration with Valneva PR Newswire

Sep 9, 2021

04:02PM EDT Dynavax to Present at the H.C. Wainwright 23rd Annual Global Investment PR Newswire

Sep 5, 2021

01:14PM EDT The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week Benzinga

Sep 2, 2021

04:02PM EDT Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

08:20AM EDT The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab Benzinga

Sep 1, 2021

07:32AM EDT The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering Benzinga

Aug 31, 2021

08:15AM EDT The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical Benzinga

06:11AM EDT HC Wainwright & Co. Maintains Buy on Dynavax Technologies, Raises Price Target to $23 Benzinga

Aug 27, 2021

10:32AM EDT Seeing Dynavax Technologies Block Trade Of 859K Shares At $18.34/Share Benzinga

10:30AM EDT Seeing Dynavax Technologies Block Of 859K Shares At $18.28/Share Benzinga

07:35AM EDT The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration Benzinga

Aug 26, 2021

01:53PM EDT Dynavax Technologies Option Alert: Jan, 2023 $20 Calls Sweep (35) near the Ask: 175 @ $6.401 vs 151 OI; Ref=$17.935 Benzinga

08:09AM EDT The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO Benzinga

Aug 25, 2021

07:30AM EDT The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug Benzinga

Aug 23, 2021

08:06AM EDT Medigen Vaccine Announces Launch Of COVID-19 Vaccine MVC-COV1901 Adjuvanted With Dynavax's CpG 1018 Adjuvant RTTNews

08:02AM EDT Medigen Vaccine Biologics, Dynavax Highlight Rollout Of Its COVID-19 Vaccine, MVC-COV1901; ~600K People Expected To Receive The Medigen Vaccine This Week Benzinga

08:02AM EDT Medigen Vaccine Biologics Announces Launch of Its COVID-19 Vaccine MVC-COV1901 PR Newswire

Aug 20, 2021

02:36PM EDT Return on Capital Employed Overview: Dynavax Technologies Benzinga

Aug 13, 2021

07:43AM EDT The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO Benzinga

Aug 12, 2021

08:09AM EDT The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma Benzinga

Aug 10, 2021

07:55AM EDT The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts Benzinga

Aug 6, 2021

10:06AM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 6, 2021 Benzinga

05:11AM EDT Goldman Sachs Initiates Coverage On Dynavax Technologies with Buy Rating, Announces Price Target of $19 Benzinga

Aug 5, 2021

08:10AM EDT 10 Biggest Price Target Changes For Thursday Benzinga

06:16AM EDT HC Wainwright & Co. Maintains Buy on Dynavax Technologies, Raises Price Target to $20 Benzinga

Aug 4, 2021

04:55PM EDT Dynavax Technologies Q2 EPS $0.02 Beats $(0.04) Estimate, Sales $52.77M Beat $41.59M Estimate Benzinga

04:02PM EDT Dynavax Announces Second Quarter 2021 Financial Results PR Newswire

04:10AM EDT Earnings Scheduled For August 4, 2021 Benzinga

Aug 3, 2021

04:10PM EDT Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

Aug 1, 2021

11:19AM EDT The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs Benzinga

Jul 21, 2021

04:02PM EDT Dynavax to Report Second Quarter 2021 Financial Results and Host Conference PR Newswire

Jul 7, 2021

03:17PM EDT Dynavax Shares Tick Higher On Volume Following Sam.gov Contract Opportunity From CDC For Co.'s '2021 Vaccines For Adults (VFA)' Benzinga

Jul 6, 2021

08:25AM EDT Biological E. Limited, a Hyderabad-based vaccine and pharmaceutical company, agreed to buy CpG 1018 adjuvant from Dynavax Technologies Corp. (DVAX) for use in the commercial production of Biological E's COVID-19 vaccine candidate, CORBEVAX. RTTNews

08:10AM EDT Dynavax, Biological E Announce Commercial Deal Of Dynavax's CpG 1018 Adjuvant For Biological E's CORBEVAX RTTNews

08:02AM EDT Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG PR Newswire

08:01AM EDT Dynavax And Biological E Announce Execution Of Commercial Supply Agreement Of Dynavax's CpG 1018 Adjuvant For Biological E's COVID-19 Vaccine Candidate Benzinga

Jul 2, 2021

04:13PM EDT Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) RTTNews

Jun 30, 2021

11:04AM EDT Clover, Dynavax Ink Commercial Supply Agreement For CpG 1018 Adjuvant Benzinga

07:29AM EDT The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs Benzinga

07:01AM EDT Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 PR Newswire

06:08AM EDT Clover To Procure CpG 1018 Adjuvant From Dynavax For Use In Commercial Production Of Clover's COVID-19 Vaccine Candidate, SCB-2019 (CpG 1018/Alum) Benzinga

04:59AM EDT Clover Biopharmaceuticals, a Chinese clinical-stage biotechnology company, announced Wednesday a commercial supply agreement with biopharmaceutical company Dynavax Technologies Corp. (DVAX). RTTNews

04:06AM EDT Clover, Dynavax Announce Commercial Supply Deal Of Dynavax's CpG 1018 Adjuvant For COVID-19 Vaccine Candidate RTTNews

04:01AM EDT Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 PR Newswire

Jun 29, 2021

04:05PM EDT Dynavax Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

Jun 9, 2021

04:06PM EDT Dynavax to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference PR Newswire

Jun 3, 2021

03:32PM EDT Valneva Concludes Recruitment for COVID-19 Vaccine Candidate Trial Benzinga

May 27, 2021

08:47AM EDT Dynavax, Bavarian Nordic Ink Distribution Pact For Hepatitis B Vaccine In Germany Benzinga

07:05AM EDT Dynavax Announces Agreement With Bavarian Nordic For Commercialization Of HEPLISAV B; Financial Terms Not Disclosed Benzinga

07:01AM EDT HEPLISAV B(r), a Two Dose Adult Hepatitis B Adjuvanted Vaccine, in Germany PR Newswire

May 24, 2021

09:48AM EDT Dynavax Technologies Option Alert: Jun 18 $8 Calls Sweep (11) near the Ask: 1000 @ $0.5 vs 426 OI; Ref=$7.75 Benzinga

May 19, 2021

04:06PM EDT Dynavax to Present at the William Blair 41st Annual Growth Stock Conference PR Newswire

07:09AM EDT India's Biological E To Make Johnson & Johnson's COVID-19 Shots: Reuters Benzinga

May 11, 2021

07:31AM EDT Dynavax Reports Pricing Of $200 Mln Convertible Senior Notes Offering RTTNews

07:31AM EDT Dynavax Announces Pricing of $200 Million Convertible Senior Notes Offering PR Newswire

May 10, 2021

07:49AM EDT Dynavax Plans Proposed Private Offering Of $200 Mln Of Convertible Senior Notes RTTNews

07:10AM EDT Dynavax Announces Proposed Private Offering of $200 Million of Convertible PR Newswire

May 6, 2021

04:37PM EDT Dynavax Technologies Q1 EPS $0.01 Beats $(0.02) Estimate, Sales $83.30M Beat $59.11M Estimate Benzinga

04:03PM EDT Dynavax Announces First Quarter 2021 Financial Results PR Newswire

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

May 4, 2021

04:02PM EDT Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

Apr 27, 2021

08:03AM EDT Dynavax Highlights Presentation Of HEPLISAV-B Post-Marketing Observational Study Results At 2021 Annual Conference On Vaccinology Research Benzinga

08:03AM EDT HEPLISAV-B Post-Marketing Observational Study Results Presented at 2021 Annual PR Newswire

Apr 22, 2021

04:06PM EDT Dynavax to Report First Quarter 2021 Financial Results and Host Conference Call PR Newswire

Apr 21, 2021

04:06PM EDT Valneva Initiates Pivotal Phase 3 Clinical Trial for its Inactivated, COVID-19 Vaccine Candidate using Dynavax's CpG 1018 Adjuvant Benzinga

04:01PM EDT Valneva Initiates Pivotal Phase 3 Clinical Trial for its Inactivated, COVID-19 PR Newswire

Apr 19, 2021

04:11PM EDT Dynavax Says 2 HEPLISAV-B Abstracts Selected For Oral Presentation At 2021 ACVR Conference Benzinga

04:10PM EDT Two HEPLISAV-B Abstracts Selected for Oral Presentation at the 2021 Annual PR Newswire

Apr 6, 2021

09:38AM EDT Valneva's COVID-19 Vaccine Candidate Using Dynavax's Adjuvant Shows Positive Interim Results Benzinga

08:05AM EDT The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout Benzinga

06:23AM EDT Valneva Reports Positive Results From Trial Of COVID-19 RTTNews

06:07AM EDT Valneva Reports Positive Initial Results Of Phase 1/2 Clinical Trial Of LA2001 Using Dynavax's CpG 1018 Adjuvant RTTNews

06:03AM EDT Dynavax Announces Valneva SE Reported Results From Part A Of Phase 1/2 Trial Of Its COVID-19 Vaccine Using Dynavax's CpG 1018 Adjuvant; Valneva Plans To Commence Phase 3 Trial By End Of Apr. Benzinga

06:01AM EDT Positive Phase 1/2 Results for Valneva's Inactivated COVID-19 Vaccine Candidate PR Newswire

Apr 2, 2021

04:05PM EDT Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

Mar 24, 2021

08:59AM EDT The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping Benzinga

08:45AM EDT Chinese biotechnology company Clover Biopharmaceuticals and US peer Dynavax Technologies Corp. (DVAX) announced Wednesday that the first participants have been dosed in Clover's SPECTRA trial. RTTNews

08:10AM EDT Clover Biopharma, Dynavax Dose First Patient In Phase 2/3 Trial For Adjuvanted S-Trimer COVID-19 Vaccine Candidate RTTNews

08:03AM EDT Clover Biopharmaceuticals And Dynavax Announce First Participants Dosed In SPECTRA Global Phase 2/3 Clinical Trial For Adjuvanted S-Trimer COVID-19 Vaccine Candidate Benzinga

08:01AM EDT SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate PR Newswire

06:46AM EDT Dynavax Stock Is Trading Higher As Adjuvanted COVID-19 Vaccine Trial Moves Forward Benzinga

Mar 1, 2021

04:16PM EST Dynavax to Present at the H.C. Wainwright Virtual 2021 Global Life Sciences PR Newswire

04:15PM EST Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

Feb 26, 2021

08:17AM EST The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida Benzinga

Feb 25, 2021

04:35PM EST Dynavax Technologies Q4 EPS $(0.14) Beats $(0.24) Estimate, Sales $19.55M Beat $13.06M Estimate Benzinga

04:03PM EST Dynavax Announces Fourth Quarter and Full Year 2020 Financial Results PR Newswire

08:08AM EST The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga

04:03AM EST Earnings Scheduled For February 25, 2021 Benzinga

Feb 24, 2021

10:04AM EST Earnings Preview for Dynavax Technologies Benzinga

Feb 23, 2021

04:43PM EST Chicago Capital LLC Discloses 5.25% Passive Stake In Dynavax Benzinga

Feb 19, 2021

12:22PM EST Dynavax Announces European Commission Marketing Authorization For HEPLISAV B 2 Dose Adult Hepatitis B Adjuvanted Vaccine Benzinga

12:21PM EST Dynavax Announces European Commission Marketing Authorization for HEPLISAV PR Newswire

Feb 16, 2021

04:06PM EST Dynavax to Present at the Cowen 41st Annual Health Care Conference PR Newswire

Feb 11, 2021

04:06PM EST Dynavax to Report Fourth Quarter and Full Year 2020 Financial Results and Host PR Newswire

Feb 9, 2021

08:10AM EST The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement Benzinga

Feb 8, 2021

04:14PM EST Dong Yu, Ph.D., Joins Dynavax as Senior Vice President of Vaccine Research PR Newswire

Feb 4, 2021

04:06PM EST Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

11:04AM EST Dynavax, Serum Institute Start Phase 1 Trial For Tdap Booster Vaccine Benzinga

08:11AM EST Dynavax and Serum Institute of India Announce First Participant Dosed in a Phase 1 Clinical Trial Evaluating an Improved Tdap Vaccine Adjuvanted with CpG 1018 Benzinga

08:07AM EST Dynavax, SIIPL: First Participant Dosed In Phase 1 Trial Evaluating Improved Tdap Vaccine Adjuvanted With CpG 1018 RTTNews

08:01AM EST Phase 1 Clinical Trial Evaluating an Improved Tdap Vaccine Adjuvanted with CpG 1018 PR Newswire

Feb 1, 2021

02:36PM EST Mid-Afternoon Market Update: Dow Jumps Over 300 Points; Viela Bio Shares Spike Higher Benzinga

12:24PM EST HC Wainwright & Co. Maintains Buy on Dynavax Technologies, Raises Price Target to $15 Benzinga

10:35AM EST Looking Into Dynavax Technologies's Return On Capital Employed Benzinga

07:24AM EST Clover Biopharmaceuticals plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 vaccine candidate adjuvanted with Dynavax Technologies Corp.'s (DVAX) CpG 1018 plus alum in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. RTTNews

07:20AM EST Dynavax, CEPI Announce $99 Mln In Funding For CpG 1018 Adjuvant Manufacturing To Support COVID-19 Response RTTNews

07:09AM EST Dynavax Announces Exercise Of Option to Reserve Additional CpG 1018 To Produce 40M Doses Of Valneva's Inactivated, Adjuvanted COVID-19 Vaccine Candidate For The UK Government Benzinga

07:08AM EST Clover, Dynavax Announce Planned Global Phase 2/3 Efficacy Trial Of Adjuvanted COVID-19 Vaccine Candidate RTTNews

07:03AM EST Dynavax, CEPI Announce $99M In Funding For CpG 1018 Adjuvant Manufacturing Benzinga

07:02AM EST 40 Million Doses of Valneva's Inactivated, Adjuvanted COVID-19 Vaccine Candidate for the UK Government PR Newswire

07:02AM EST Dynavax and CEPI Announce $99 Million in Funding for CpG 1018 Adjuvant PR Newswire

07:01AM EST Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of PR Newswire

06:25AM EST Dynavax Shares Up 17% Premarket; Clover and Dynavax Announced Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate Benzinga

Jan 25, 2021

08:18AM EST Medigen COVID-19 Vaccine Adjuvanted With Dynavax's CpG 1018 Announces First Participant Dosed In Phase 2 Trial In Taiwan RTTNews

08:03AM EST Medigen Vaccine Biologics COVID-19 Vaccine Adjuvanted with Dynavax's CpG 1018 PR Newswire

08:02AM EST Dynavax, Medigen Vaccine Biologics Report First Patient Dosed In Phase 2 Trial Of COVID-19 Vaccine Candidate, MVC-COV1901 Benzinga

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

Jan 20, 2021

04:06PM EST Dynavax Appoints Kelly MacDonald As CFO RTTNews

04:06PM EST Dynavax Appoints Kelly MacDonald as Chief Financial Officer PR Newswire

04:06PM EST Dynavax Names Kelly MacDonald CFO Benzinga

Jan 7, 2021

08:19AM EST Dynavax Says Interim Results On Undergoing Hemodialysis Shows HEPLISAV-B Well Tolerated; No Safety Concerns Observed RTTNews

08:05AM EST Dynavax Announces Final Immunogenicity And Interim Safety Results From Clinical Trial Evaluating HEPLISAV-B In Patients Undergoing Hemodialysis Benzinga

08:01AM EST Dynavax Announces Final Immunogenicity and Interim Safety Results from Clinical PR Newswire

Jan 6, 2021

04:05PM EST Dynavax to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference PR Newswire

Dec 26, 2020

09:16AM EST The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks Benzinga

Dec 23, 2020

08:01AM EST Serum Institute Of India And Dynavax Announce First Participants Dosed In The PR Newswire

08:01AM EST Dynavax Announces With Serum Institute Of Indiana That First Participants Dosed In Phase 1/2 Clinical Trial For A COVID-19 Vaccine Benzinga

Dec 11, 2020

08:11AM EST The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street Benzinga

Dec 10, 2020

04:07PM EST Dynavax Technologies Reports European CHMP Adopts Positive Opinion for HEPLISAV-B, Co's Two Dose Adult Hepatitis B Adjuvanted Vaccine Benzinga

04:05PM EST European CHMP Adopts Positive Opinion for HEPLISAV-B(r), Dynavax's Two Dose PR Newswire

Dec 4, 2020

08:04AM EST The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs Benzinga

03:04AM EST Clover Reports Positive Phase 1 Data For Its Adjuvanted S-Trimer COVID-19 Vaccine Candidates RTTNews

03:00AM EST Clover Biopharmaceuticals Announces Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates Business Wire

Nov 17, 2020

04:06PM EST Dynavax to Present at the 3rd Annual Evercore Virtual ISI HealthCONx Conference PR Newswire

Nov 16, 2020

06:15AM EST Biological E. Limited has initiated a phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India following approval from the Drugs Controller General of India. The vaccine candidate includes an antigen in-licensed from BCM Ventures, Baylor College of Medicine's integrated commercialization team, along with Dynavax's (DVAX) advanced adjuvant CpG 1018. RTTNews

06:03AM EST Biological E. Limited Starts Phase I/II Clinical Trial of its COVID-19 Vaccine Candidate Benzinga

06:02AM EST Biological E. Limited Starts Phase I/II Clinical Trial Of Its COVID-19 Vaccine Candidate In India RTTNews

06:01AM EST Biological E. Limited Starts Phase I/II Clinical Trial of its COVID-19 Vaccine PR Newswire

Nov 6, 2020

06:25AM EST HC Wainwright & Co. Maintains Buy on Dynavax Technologies, Raises Price Target to $14 Benzinga

Nov 5, 2020

04:24PM EST Dynavax Technologies Q3 EPS $(0.15) Beats $(0.20) Estimate, Sales $13.41M Beat $9.44M Estimate Benzinga

04:02PM EST Dynavax Announces Third Quarter 2020 Financial Results PR Newswire

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 3, 2020

09:57AM EST Looking Into Dynavax Technologies's Return On Capital Employed Benzinga

Nov 2, 2020

04:06PM EST Dynavax to Present at the Stifel 2020 Virtual Healthcare Conference PR Newswire

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 22, 2020

04:06PM EDT Dynavax to Report Third Quarter 2020 Financial Results and Host Conference Call PR Newswire

Oct 13, 2020

06:16AM EDT Dynavax: MVC Begins Phase 1 Trial For Adjuvanted Vaccine RTTNews

06:03AM EDT Medigen's COVID-19 Vaccine Combined With Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy RTTNews

06:01AM EDT Medigen's COVID-19 Vaccine Combined With Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy With First Participant Dosed In Early October; Subsidy Will Be Released At Agreed Upon Milestones In The Total Amount Of Up To $16.4M Benzinga

06:01AM EDT Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 Adjuvant Receives PR Newswire

Sep 24, 2020

04:06PM EDT Dynavax Announces Michael Ostrach To Retire As CFO in 2021 Benzinga

04:05PM EDT Dynavax Announces Appointment of New Board Member and Planned Retirement of PR Newswire

Sep 14, 2020

09:53AM EDT Return On Capital Employed Overview: Dynavax Technologies Benzinga

05:59AM EDT Valneva and Dynavax Announced Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine; Dynavax to Provide CpG 1018 to Produce up to 190M Doses over a Five-Year Period Benzinga

01:37AM EDT Valneva and Dynavax Technologies Corp. (DVAX) have reached a commercial supply agreement for the potential COVID-19 Vaccine. Dynavax will supply its CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001. RTTNews

01:04AM EDT Valneva, Dynavax Announce Commercial Partnership For Supply Of Dynavax's CpG 1018 Adjuvant For Use In Valneva's VLA2001 RTTNews

01:00AM EDT Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, PR Newswire

Aug 31, 2020

04:10PM EDT Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that Ryan Spencer, Chief Executive Officer, will participate in a virtual fireside chat at the H.C. Wainwright Virtual 22ndAnnual Global Investment Conference on Monday, September 14, at 10:00 a.m. ET. GlobeNewswire Inc

Aug 13, 2020

08:37AM EDT Dynavax Gets Funding From Bill & Melinda Gates Foundation RTTNews

08:23AM EDT Dynavax Reports $3.4M Grant From Bill & Melinda Gates Foundation To Scale Up cpG 1018 Adjuvant Capacity To Support Coronavirus Reponse Benzinga

08:12AM EDT Dynavax Gets Grant From The Bill & Melinda Gates Foundation To Scale Up CpG 1018 Adjuvant Capacity RTTNews

08:00AM EDT Dynavax Announces Grant to Scale up CpG 1018 Adjuvant Capacity to GlobeNewswire Inc

Aug 12, 2020

12:39PM EDT DVAX Dynavax Technologies Option Alert: Aug 21 $7 Calls at the Ask: 300 @ $0.69 vs 554 OI; Ref=$6.903 Benzinga

10:55AM EDT Dynavax Shares Move Higher As Traders Circulate bioRxiv Abstract For 'Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19' Benzinga

Aug 7, 2020

06:46AM EDT HC Wainwright & Co. Maintains Buy on Dynavax Technologies, Lowers Price Target to $12 Benzinga

Aug 6, 2020

04:36PM EDT Dynavax Technologies Q2 EPS $(0.53) Up From $(0.66) YoY, Sales $2.67M Miss $5.55M Estimate Benzinga

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

Aug 5, 2020

11:56AM EDT Return On Capital Employed Overview: Dynavax Technologies Benzinga

Aug 3, 2020

03:53PM EDT Why Dynavax's Stock Is Trading Higher Today Benzinga

11:51AM EDT HC Wainwright & Co. Maintains Buy on Dynavax Technologies, Raises Price Target to $14 Benzinga

08:08AM EDT TriSalus Life Sciences Acquires Dynavax's SD-101 Oncology Program In Purchase Agreement For Up To $250M In Milestone Payments Plus Royalties On Future Net Sales Benzinga

08:00AM EDT -- SD-101 is a proprietary investigational, second-generation, Toll-like receptor 9 (TLR9) agonist CpG-C class oligodeoxynucleotide -- TriSalus plans to further develop SD-101 as an oncology therapeutic GlobeNewswire Inc

Jul 23, 2020

03:59PM EDT Dynavax Technologies shares are trading higher after the company announced it will collaborate with Medigen to develop a novel adjuvanted COVID-19 vaccine candidate. UPDATE: Shares have since reversed. Benzinga

08:50AM EDT Dynavax Technologies Corp. (DVAX) and Medigen Vaccine Biologics Corp. (MVC) have collaborated to develop an adjuvanted vaccine candidate to protect against COVID-19. RTTNews

08:32AM EDT Dynavax, MVC Collaborate To Develop A Novel Adjuvanted COVID-19 Vaccine Candidate RTTNews

08:02AM EDT Dynavax And Medigen Announce Collaboration To Develop A Novel Adjuvanted COVID-19 Vaccine Candidate Benzinga

08:00AM EDT -- Collaboration focused on developing an adjuvanted COVID-19 vaccine using Medigens subunit vaccine candidate with Dynavaxs CpG 1018 -- In preclinical testing, the combination generated strong virus neutralizing antibody responses -- Medigen anticipates initiating a Phase 1 clinical trial evaluating the combination in September 2020 GlobeNewswire Inc

Jul 21, 2020

04:10PM EDT -- Ms. Julie Eastland, a strategic and financial executive with over 25 years of experience in biotechnology companies -- Mr. Brent MacGregor, a senior executive with over 20 years of global strategy and commercial experience in the vaccines industry GlobeNewswire Inc

10:27AM EDT Shares of Dynavax Technologies Corp. (DVAX) are currently losing nearly 12% on Tuesday morning despite no stock-specific news. RTTNews

Jul 20, 2020

03:46PM EDT Shares of several coronavirus vaccine companies are trading lower after early results of AstraZeneca & Oxford University's coronavirus vaccine were released. Benzinga

05:11AM EDT 80 Biggest Movers From Friday Benzinga

Jul 17, 2020

11:23AM EDT Why Dynavax's Stock Is Trading Higher Today Benzinga

Jul 16, 2020

10:08AM EDT Dynavax shares are trading higher after the company announced a collaboration with Mount Sinai to develop a universal flu vaccine candidate with CpG 1018 adjuvant. Benzinga

08:47AM EDT Dynavax Reports Collaboration With Mount Sinai To Develop Universal Flu Vaccine Candidate With CpG 1018 Adjuvant Benzinga

08:40AM EDT -- Development funded under contract award from NIAID/NIH as part of the CIVICs program -- Currently no approved universal influenza vaccine -- CDC estimates 35.5 million people were infected with influenza in U.S. during 2018-2019 season -- Collaboration will combine Dynavaxs CpG 1018 with influenza antigens designed to protect against all strains of influenza GlobeNewswire Inc

Jul 14, 2020

11:28AM EDT Why Dynavax's Stock Is Trading Higher Today Benzinga

08:29AM EDT Dynavax Says First Participants Dosed In Phase 1 Clinical Trial Of COVID-19 Vaccine Candidate With CpG 1018 Adjuvant RTTNews

08:18AM EDT Dynavax Announces First Participants Dosed In Phase 1 Clinical Trial Evaluating Medicago's COVID-19 Vaccine Candidate With Dynavax's CpG 1018 Adjuvant Benzinga

08:01AM EDT -- Medicago expects to enroll 180 healthy adult participants -- Preliminary safety and immunogenicity results are expected in October 2020 -- Dynavax is providing CpG 1018, the adjuvant contained in its U.S. FDA-approved adult hepatitis B vaccine, to enhance the immune response of Medicagos COVID-19 vaccine candidate GlobeNewswire Inc

Share